Success Metrics

Clinical Success Rate
84.2%

Based on 64 completed trials

Completion Rate
84%(64/76)
Active Trials
12(9%)
Results Posted
30%(19 trials)
Terminated
12(9%)

Phase Distribution

Ph phase_3
27
19%
Ph phase_1
14
10%
Ph phase_2
31
22%
Ph phase_4
26
19%
Ph early_phase_1
1
1%
Ph not_applicable
39
28%

Phase Distribution

15

Early Stage

31

Mid Stage

53

Late Stage

Phase Distribution138 total trials
Early Phase 1First-in-human
1(0.7%)
Phase 1Safety & dosage
14(10.1%)
Phase 2Efficacy & side effects
31(22.5%)
Phase 3Large-scale testing
27(19.6%)
Phase 4Post-market surveillance
26(18.8%)
N/ANon-phased studies
39(28.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.0%

64 of 81 finished

Non-Completion Rate

21.0%

17 ended early

Currently Active

12

trials recruiting

Total Trials

140

all time

Status Distribution
Active(19)
Completed(64)
Terminated(17)
Other(40)

Detailed Status

Completed64
unknown40
Terminated12
Recruiting9
Not yet recruiting6
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
140
Active
12
Success Rate
84.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.7%)
Phase 114 (10.1%)
Phase 231 (22.5%)
Phase 327 (19.6%)
Phase 426 (18.8%)
N/A39 (28.3%)

Trials by Status

terminated129%
withdrawn54%
unknown4029%
completed6446%
enrolling_by_invitation11%
recruiting96%
active_not_recruiting32%
not_yet_recruiting64%

Recent Activity

Clinical Trials (140)

Showing 20 of 140 trialsScroll for more
NCT06176248Not Applicable

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis

Recruiting
NCT04207931Phase 4

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Recruiting
NCT07471997Not Applicable

Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

Completed
NCT07453238Phase 4

Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata

Not Yet Recruiting
NCT07004465Not Applicable

Effectiveness of Vitamin b12 Versus Kenalog on Traumatic Ulcer Associated With Orthodontic Treatment

Completed
NCT07420166Not Applicable

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

Completed
NCT05436535Phase 4

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Completed
NCT07409571Not Applicable

Palatal Wound Healing After Free Gingival Graft Surgery

Recruiting
NCT04002362Phase 2

Symptom Clusters in Children With Exacerbation-prone Asthma

Completed
NCT06327581Not Applicable

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Recruiting
NCT06401317Phase 2

Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)

Recruiting
NCT06977568Phase 2

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip

Terminated
NCT07277998Not Applicable

Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis

Not Yet Recruiting
NCT05190770Phase 2

A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer

Completed
NCT05535738Phase 2

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Recruiting
NCT07189572Phase 3

Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma

Not Yet Recruiting
NCT07194135Not Applicable

Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management

Completed
NCT07141446Phase 1

Evaluation of Efficacy of Neem (Azadirachta Indica) Versus Triamcinolone Acetonide in the Treatment of Oral Lichen Planus.

Completed
NCT07114016Phase 4

Efficacy of Topical Glucosamine Versus Corticosteroid in Oral Lichen Planus

Completed
NCT04469075Phase 2

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
140